Latest stories on MIRM
Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress
Yahoo Top67 · bullishproduct/pr
Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance
Yahoo Finance67 · bullishproduct/pr